Progressive Myoclonus Epilepsy Syndromes

Progressive myoclonus epilepsy syndromes comprise a heterogeneous group of inherited neurological disorders characterised by the combination of myoclonic jerks, generalised tonic–clonic seizures and progressive neurological decline. Typically manifesting in childhood or adolescence, these syndromes often include cerebellar ataxia, cognitive impairment and varying degrees of motor dysfunction. The underlying pathology involves cortical and subcortical networks that become hyperexcitable, leading to the hallmark sudden, shock-like muscle contractions. Molecular genetic advances have revealed diverse causative genes, many encoding proteins involved in lysosomal function, synaptic transmission or ion channel regulation. Clinically, the major recognised entities include Unverricht–Lundborg disease, Lafora disease, neuronal ceroid lipofuscinoses and several rarer novel forms. Despite shared features, each subtype follows a distinct trajectory of seizure severity, ataxia progression and cognitive involvement. Management remains largely symptomatic, focusing on antiseizure medications and supportive therapies, although emerging gene-targeted strategies and personalised approaches are under investigation. Comprehensive genetic diagnosis and early intervention are crucial to optimise functional outcomes and to guide future disease-modifying therapies.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Progressive Myoclonus Epilepsy Syndromes publication trend

The graph below shows the total number of articles in progressive myoclonus epilepsy syndromes across all publications each year (not limited to Nature Index journals).

Technical terms

Myoclonus: Sudden, brief, involuntary muscle jerks resulting from abnormal neuronal firing.

Ataxia: Impaired coordination of voluntary movements, often manifesting as unsteady gait or intention tremor.

Whole exome sequencing: A genomic technique that selectively sequences all protein-coding regions to identify pathogenic variants.

Genotype–phenotype correlation: The relationship between specific genetic variants and the clinical manifestations of a disorder.

References

1. Novel Genetic and Phenotypic Expansion in GOSR2-Related Progressive Myoclonus Epilepsy. Genes (2023).
2. Genetic profile of progressive myoclonic epilepsy in Mali reveals novel findings. Frontiers in Neurology (2024).
3. Unverricht-Lundborg Disease: Tackling the Challenges of a Complex Clinical Picture. Sinapse (2024).